GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (MEX:ILMN) » Definitions » Cyclically Adjusted FCF per Share

Illumina (MEX:ILMN) Cyclically Adjusted FCF per Share : MXN100.99 (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Illumina Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Illumina's adjusted free cash flow per share for the three months ended in Mar. 2025 was MXN25.862. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN100.99 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Illumina's average Cyclically Adjusted FCF Growth Rate was 7.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 3.30% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 5.30% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 14.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Illumina was 139.10% per year. The lowest was 3.30% per year. And the median was 22.40% per year.

As of today (2025-05-28), Illumina's current stock price is MXN1614.96. Illumina's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was MXN100.99. Illumina's Cyclically Adjusted Price-to-FCF of today is 15.99.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Illumina was 186.44. The lowest was 14.86. And the median was 88.08.


Illumina Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Illumina's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina Cyclically Adjusted FCF per Share Chart

Illumina Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.27 87.28 78.93 74.19 100.13

Illumina Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.48 83.85 88.22 100.13 100.99

Competitive Comparison of Illumina's Cyclically Adjusted FCF per Share

For the Diagnostics & Research subindustry, Illumina's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Illumina's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Illumina's Cyclically Adjusted Price-to-FCF falls into.


;
;

Illumina Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Illumina's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=25.862/134.9266*134.9266
=25.862

Current CPI (Mar. 2025) = 134.9266.

Illumina Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 13.673 100.684 18.323
201509 17.108 100.392 22.993
201512 38.330 99.792 51.825
201603 5.350 100.470 7.185
201606 21.742 101.688 28.849
201609 14.110 101.861 18.690
201612 25.075 101.863 33.214
201703 10.888 102.862 14.282
201706 13.403 103.349 17.498
201709 18.516 104.136 23.991
201712 28.928 104.011 37.526
201803 20.254 105.290 25.955
201806 28.943 106.317 36.732
201809 28.622 106.507 36.259
201812 30.357 105.998 38.642
201903 18.487 107.251 23.258
201906 12.376 108.070 15.452
201909 29.079 108.329 36.219
201912 48.859 108.420 60.804
202003 38.182 108.902 47.307
202006 31.348 108.767 38.887
202009 15.673 109.815 19.257
202012 46.235 109.897 56.765
202103 33.373 111.754 40.293
202106 28.302 114.631 33.313
202109 -43.543 115.734 -50.764
202112 27.700 117.630 31.773
202203 13.900 121.301 15.461
202206 6.920 125.017 7.469
202209 -38.180 125.227 -41.137
202212 29.679 125.222 31.979
202303 -4.906 127.348 -5.198
202306 6.293 128.729 6.596
202309 10.473 129.860 10.882
202312 18.586 129.419 19.377
202403 4.280 131.776 4.382
202406 5.646 132.554 5.747
202409 34.950 133.029 35.449
202412 43.941 133.157 44.525
202503 25.862 134.927 25.862

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Illumina  (MEX:ILMN) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Illumina's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=1614.96/100.99
=15.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Illumina was 186.44. The lowest was 14.86. And the median was 88.08.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Illumina Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Illumina's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Illumina Business Description

Address
5200 Illumina Way, San Diego, CA, USA, 92122
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.